Cargando…

Comparing the clinical and singleton neonatal outcomes in male infertility patients with Oligoasthenospermia, OA, or NOA following fresh ICSI-ET using different sources of sperm

OBJECTIVE: To investigate clinical and singleton newborn outcomes in fresh cycles of embryo transfer after intracytoplasmic sperm injection (ICSI-ET) with diverse sperm sources (ejaculate, epididymis, and testis) in patients with Oligoasthenospermia, obstructive azoospermia (OA) or non-obstructive a...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jianmin, Yang, Qingling, Chen, Wenhui, Jiang, Yuqing, Shen, Zhaoyang, Wang, Huan, Sun, Yingpu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663326/
https://www.ncbi.nlm.nih.gov/pubmed/38027205
http://dx.doi.org/10.3389/fendo.2023.1186257
_version_ 1785138375183826944
author Xu, Jianmin
Yang, Qingling
Chen, Wenhui
Jiang, Yuqing
Shen, Zhaoyang
Wang, Huan
Sun, Yingpu
author_facet Xu, Jianmin
Yang, Qingling
Chen, Wenhui
Jiang, Yuqing
Shen, Zhaoyang
Wang, Huan
Sun, Yingpu
author_sort Xu, Jianmin
collection PubMed
description OBJECTIVE: To investigate clinical and singleton newborn outcomes in fresh cycles of embryo transfer after intracytoplasmic sperm injection (ICSI-ET) with diverse sperm sources (ejaculate, epididymis, and testis) in patients with Oligoasthenospermia, obstructive azoospermia (OA) or non-obstructive azoospermia (NOA). METHODS: Patients who received fresh ICSI-ET for the first time at the First Affiliated Hospital of Zhengzhou University Reproductive Medicine Center between June 2011 and June 2021 were selected for this 10-year retrospective cohort analysis. After propensity score matching, only 1630 cycles were included in the investigation of ICS-ET clinical and singleton newborn outcomes in patients with Oligoasthenospermia, OA, and NOA using sperm from diverse sperm sources. RESULT(S): After propensity score matching, our data revealed a negligible difference in baseline and cycle parameters among groups. In patients with Oligoasthenospermia and OA, different sperm sources do not appear to influence clinical pregnancy rates and live birth rates, nor do they influence newborn outcomes, such as newborn weight, premature birth rate, and neonatal sex ratio in singleton births, except for OA patients who use epididymal sperm having higher low birth weight (LBW) rates in singleton pregnancies than those who use testicular sperm. In addition, clinical pregnancy rates, live birth rates, singleton gestation birth weights, premature birth rates, and neonatal sex ratios were similar between patients with Oligoasthenospermia, OA, and NOA using testicular sperm. CONCLUSION(S): Regardless of the type of male infertility (Oligoasthenospermia, OA, NOA) or sperm sources (ejaculate, epididymis, testis), a successful ICSI-ET procedure can result in similar clinical and neonatal outcomes, such as clinical pregnancy rate, live birth rate, abortion rate, neonatal birth weight and sex ratio of singleton pregnancies.
format Online
Article
Text
id pubmed-10663326
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-106633262023-01-01 Comparing the clinical and singleton neonatal outcomes in male infertility patients with Oligoasthenospermia, OA, or NOA following fresh ICSI-ET using different sources of sperm Xu, Jianmin Yang, Qingling Chen, Wenhui Jiang, Yuqing Shen, Zhaoyang Wang, Huan Sun, Yingpu Front Endocrinol (Lausanne) Endocrinology OBJECTIVE: To investigate clinical and singleton newborn outcomes in fresh cycles of embryo transfer after intracytoplasmic sperm injection (ICSI-ET) with diverse sperm sources (ejaculate, epididymis, and testis) in patients with Oligoasthenospermia, obstructive azoospermia (OA) or non-obstructive azoospermia (NOA). METHODS: Patients who received fresh ICSI-ET for the first time at the First Affiliated Hospital of Zhengzhou University Reproductive Medicine Center between June 2011 and June 2021 were selected for this 10-year retrospective cohort analysis. After propensity score matching, only 1630 cycles were included in the investigation of ICS-ET clinical and singleton newborn outcomes in patients with Oligoasthenospermia, OA, and NOA using sperm from diverse sperm sources. RESULT(S): After propensity score matching, our data revealed a negligible difference in baseline and cycle parameters among groups. In patients with Oligoasthenospermia and OA, different sperm sources do not appear to influence clinical pregnancy rates and live birth rates, nor do they influence newborn outcomes, such as newborn weight, premature birth rate, and neonatal sex ratio in singleton births, except for OA patients who use epididymal sperm having higher low birth weight (LBW) rates in singleton pregnancies than those who use testicular sperm. In addition, clinical pregnancy rates, live birth rates, singleton gestation birth weights, premature birth rates, and neonatal sex ratios were similar between patients with Oligoasthenospermia, OA, and NOA using testicular sperm. CONCLUSION(S): Regardless of the type of male infertility (Oligoasthenospermia, OA, NOA) or sperm sources (ejaculate, epididymis, testis), a successful ICSI-ET procedure can result in similar clinical and neonatal outcomes, such as clinical pregnancy rate, live birth rate, abortion rate, neonatal birth weight and sex ratio of singleton pregnancies. Frontiers Media S.A. 2023-11-08 /pmc/articles/PMC10663326/ /pubmed/38027205 http://dx.doi.org/10.3389/fendo.2023.1186257 Text en Copyright © 2023 Xu, Yang, Chen, Jiang, Shen, Wang and Sun https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Xu, Jianmin
Yang, Qingling
Chen, Wenhui
Jiang, Yuqing
Shen, Zhaoyang
Wang, Huan
Sun, Yingpu
Comparing the clinical and singleton neonatal outcomes in male infertility patients with Oligoasthenospermia, OA, or NOA following fresh ICSI-ET using different sources of sperm
title Comparing the clinical and singleton neonatal outcomes in male infertility patients with Oligoasthenospermia, OA, or NOA following fresh ICSI-ET using different sources of sperm
title_full Comparing the clinical and singleton neonatal outcomes in male infertility patients with Oligoasthenospermia, OA, or NOA following fresh ICSI-ET using different sources of sperm
title_fullStr Comparing the clinical and singleton neonatal outcomes in male infertility patients with Oligoasthenospermia, OA, or NOA following fresh ICSI-ET using different sources of sperm
title_full_unstemmed Comparing the clinical and singleton neonatal outcomes in male infertility patients with Oligoasthenospermia, OA, or NOA following fresh ICSI-ET using different sources of sperm
title_short Comparing the clinical and singleton neonatal outcomes in male infertility patients with Oligoasthenospermia, OA, or NOA following fresh ICSI-ET using different sources of sperm
title_sort comparing the clinical and singleton neonatal outcomes in male infertility patients with oligoasthenospermia, oa, or noa following fresh icsi-et using different sources of sperm
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663326/
https://www.ncbi.nlm.nih.gov/pubmed/38027205
http://dx.doi.org/10.3389/fendo.2023.1186257
work_keys_str_mv AT xujianmin comparingtheclinicalandsingletonneonataloutcomesinmaleinfertilitypatientswitholigoasthenospermiaoaornoafollowingfreshicsietusingdifferentsourcesofsperm
AT yangqingling comparingtheclinicalandsingletonneonataloutcomesinmaleinfertilitypatientswitholigoasthenospermiaoaornoafollowingfreshicsietusingdifferentsourcesofsperm
AT chenwenhui comparingtheclinicalandsingletonneonataloutcomesinmaleinfertilitypatientswitholigoasthenospermiaoaornoafollowingfreshicsietusingdifferentsourcesofsperm
AT jiangyuqing comparingtheclinicalandsingletonneonataloutcomesinmaleinfertilitypatientswitholigoasthenospermiaoaornoafollowingfreshicsietusingdifferentsourcesofsperm
AT shenzhaoyang comparingtheclinicalandsingletonneonataloutcomesinmaleinfertilitypatientswitholigoasthenospermiaoaornoafollowingfreshicsietusingdifferentsourcesofsperm
AT wanghuan comparingtheclinicalandsingletonneonataloutcomesinmaleinfertilitypatientswitholigoasthenospermiaoaornoafollowingfreshicsietusingdifferentsourcesofsperm
AT sunyingpu comparingtheclinicalandsingletonneonataloutcomesinmaleinfertilitypatientswitholigoasthenospermiaoaornoafollowingfreshicsietusingdifferentsourcesofsperm